Clinical Trials Directory

Trials / Unknown

UnknownNCT02163642

Role of Innate Immunity in Non-Cystic Fibrosis Bronchiectasis

Bronchial Infections in Patients With Non-Cystic Fibrosis (CF) Bronchiectasis; Role of Innate Lung Defense Mechanisms and Utility of an Electronic Nose for Its Diagnosis

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate that 1) the secretion of mucins, antimicrobial peptides and Toll-like receptors is altered in certain patients with non-CF bronchiectasis, which makes them more susceptible to be infected by potentially pathogenic bacteria (PPB); and 2) the electronic nose is able to detect patterns of specific Volatile Organic Compounds (VOC) for patients with non-CF bronchiectasis colonized by PPB.

Detailed description

Prospective, observational study, which will include 50 patients with non-CF bronchiectasis who will be followed for a period of 12 months. A follow up control will be performed every three months to all patients, consisting in medical record, lung function tests, blood and serum collection, sputum analysis and culture, and collection of exhaled air for analysis using an electronic nose. These tests will also be repeated whenever the patient has an exacerbation. At the beginning and end of the study, a high resolution chest CT will be performed.

Conditions

Interventions

TypeNameDescription
DEVICECyranose® 320Detection of patterns of specific Volatile Organic Compounds in exhaled air

Timeline

Start date
2014-04-01
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2014-06-13
Last updated
2016-09-08

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02163642. Inclusion in this directory is not an endorsement.